Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital workouts tested as back pain relief

NCT ID NCT07208435

Symptom relief Sponsor: Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a web-based exercise program to traditional home exercises for people with non-specific low back pain. Thirty adults aged 18-45 with moderate pain will follow an 8-week program using an app. Researchers will measure changes in pain, function, and quality of life to see if the digital approach works as well as standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Web-based therapeutic exercise program
What this could lead to
If successful, this could offer a convenient, digital alternative to traditional home exercise programs for managing low back pain.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply to everyone. The web-based approach may not suit all patients or improve outcomes significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-45 years diagnosed with non-specific low back pain (NSLBP) for 6 weeks to \<12 months. * Self-reported pain intensity ≥3 on a 0-10 Numeric Pain Rating Scale (NPRS). * Evidence of functional limitation (Oswestry Disability Index or Roland-Morris Disability Questionnaire). * Access to a smartphone, tablet, or computer with internet connectivity. * Ability and willingness to participate in telerehabilitation programs. Exclusion Criteria: * Specific causes of low back pain (herniated disc with radiculopathy, spinal stenosis, spondylolisthesis, fractures, infections, malignancy). * Neurological deficits (e.g., severe motor weakness, progressive neurological symptoms). * Severe psychiatric or cognitive disorders interfering with participation. * History of spinal surgery within the last year. * Severe comorbidities contraindicating exercise (e.g., uncontrolled diabetes, cardiovascular disease). * Pregnant or planning pregnancy during the study period. * Active substance or alcohol abuse. * Participation in other structured rehabilitation or physical therapy programs within the last 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non-specific low back pain (NSLBP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Non-specific low back pain (NSLBP)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul Medipol University

    Istanbul, Beykoz, 34810, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.